Skip to main content
Premium Trial:

Request an Annual Quote

Lophius Biosciences Signs Exclusive Korean Distribution Agreement with BL&H

NEW YORK (GenomeWeb) – German T-cell research tools firm Lophius Biosciences today announced an exclusive distribution agreement with BL&H for its T-Track CMV kit in South Korea.

Under the terms of the agreement, BL&H will market and sell the test to transplantation centers. The diagnostic assay combines ELISpot assay technology with T-activation technology to measure cytomegalovirus-specific cell mediated immunity in immunocompromised patients.

The kit is currently sold for research-use only, but Lophius said in a statement it expects the Korean Ministry of Food and Drug Safety to approve the test and will make it available as an in vitro diagnostic in the country by the end of 2016.

The deal includes unspecified milestone payments to Lophius from BL&H. Other financial details were not disclosed.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.